Estimation of serum n-terminal brain Natriuretic peptide levels in preterm Newborn with patent ductus arteriosus (pda) – a one year hospital based Prospective observational study

Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/1854

Full metadata record

DC Field	Value	Language
dc.contributor.author	REG N0: BM0121002	-
dc.date.accessioned	2025-04-28T11:34:48Z	-
dc.date.available	2025-04-28T11:34:48Z	-
dc.date.issued	2024	-
dc.identifier.uri	http://localhost:8080/xmlui/handle/123456789/1854	-
dc.description.abstract	Background: Patent ductus arteriosus (PDA) is frequent in neonates with a gestational age of less than 28 weeks. While clinical and echocardiographic signs determine the hemodynamic significant PDA. N-terminal peptide of Brain natriuretic peptide (NT- Pro BNP) has been suggested as a screening tool for PDA in preterm infants. Objectives: This study aims to estimate serum NT-proBNP levels in preterm newborns with PDA and assess its relationship with Hemodynamically significant PDA (Hs-PDA).	en_US
dc.language.iso	en_US	en_US
dc.publisher	KLE Academy of Higher Education and Research, Belagavi	en_US
dc.title	Estimation of serum n-terminal brain Natriuretic peptide levels in preterm Newborn with patent ductus arteriosus (pda) – a one year hospital based Prospective observational study	en_US
dc.type	Dissertations	en_US
Appears in Collections:	Pediatrics MD

Files in This Item:

File	Description	Size	Format
BM0121002.pdf		6.11 MB	Adobe PDF	View/Open